468
Views
10
CrossRef citations to date
0
Altmetric
Clinical Research

Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures

ORCID Icon, , , , & ORCID Icon
Pages 183-189 | Received 26 Mar 2019, Accepted 07 Jun 2019, Published online: 03 Jul 2019

References

  • Gummin DD, Mowry JB, Spyker DA, et al. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th annual report. Clin Toxicol. 2017;55:1072–1252.
  • Toce MS, Burns MM. The poisoned pediatric patient. Pediatr Rev. 2017;38:207–220.
  • Worldwide SK. Safe Kids Worldwide. Safe storage, safe dosing, safe kids: a report to the nation on safe medication. 2012. [cited 2018 Dec 20]. Available from https://www.safekids.org/research-report/safe-storage-safe-dosing-safe-kids-report-nation-safe-medication-march-2012
  • Pediatric Single-Dose Fatal Ingestions. 2016. [cited 2018 Dec 1]. Available from https://emedicine.medscape.com/article/1011108-overview
  • Even KM, Armsby CC, Bateman ST. Poisonings requiring admission to the pediatric intensive care unit: a 5-year review. Clin Toxicol. 2014;52:519–524.
  • Manini AF, Hoffman RS, Stimmel B, et al. Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. Acad Emerg Med. 2015;22:499–507.
  • Manini AF, Nelson LS, Stimmel B, et al. Incidence of adverse cardiovascular events in adults following drug overdose. Acad Emerg Med. 2012;19:843–849.
  • Sanborn PA, Michna E, Zurakowski D. Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations. Radiology. 2005;237:288–294.
  • McIntyre RS, Jerrell JM. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch Pediatr Adolesc Med. 2008;162:929–935.
  • Farrugia LA, Rhyee SH, Campleman SL, et al. The toxicology investigators consortium case registry – the 2015 experience. J Med Toxicol. 2016;12:224–247.
  • Albertson TE, Dawson A, de Latorre F, et al. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med. 2001;37:S78–S90.
  • Jang DH, Spyres MB, Fox L, et al. Toxin-induced cardiovascular failure. Emerg Med Clin North Am. 2014;32:79–102.
  • Manini AF, Nair AP, Vedanthan R, et al. Validation of the prognostic utility of the electrocardiogram for acute drug overdose. J Am Heart Assoc. 2017;6:pii: e004320.
  • Manini AF, Nelson LS, Skolnick AH, et al. Electrocardiographic predictors of adverse cardiovascular events in suspected poisoning. J Med Toxicol. 2010;6:106–115.
  • Vanden Hoek TL, Morrison LJ, Shuster M, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:S829–S861.
  • Zito JM, Burcu M. Stimulants and pediatric cardiovascular risk. J Child Adolesc Psychopharmacol. 2017;27:538–545.
  • Niesters M, Overdyk F, Smith T, et al. Opioid-induced respiratory depression in paediatrics: a review of case reports. Br J Anaesth. 2013;110:175–182.
  • Gostin LO, Hodge JG, Jr, Noe SA. Reframing the opioid epidemic as a national emergency. JAMA. 2017;318:1539–1540.
  • Pitt AL, Humphreys K, Brandeau ML. Modeling health benefits and harms of public policy responses to the US opioid epidemic. Am J Public Health. 2018;108:1394–1400.
  • Seth P, Scholl L, Rudd RA, et al. Overdose deaths involving opioids, cocaine, and psychostimulants – United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 2018;67:349–358.
  • Burghardt LC, Ayers JW, Brownstein JS, et al. Adult prescription drug use and pediatric medication exposures and poisonings. Pediatrics. 2013;132:18–27.
  • Olofsen E, Sarton E, Teppema L, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96:627–632.
  • Walsh SL, Preston KL, Stitzer ML, et al. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 1994;55:569–580.
  • Toce MS, Burns MM, O’Donnell KA. Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center. Clin Toxicol. 2017;55:12–17.
  • Manini AF, Stimmel B, Vlahov D. Racial susceptibility for QT prolongation in acute drug overdoses. J Electrocardiol. 2014;47:244–250.
  • Riccoboni ST, Darracq MA. Does the U stand for useless? The urine drug screen and emergency department psychiatric patients. J Emerg Med. 2018;54:500–506.
  • Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473–1482.
  • Roden DM, Woosley RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J. 1986;111:1088–1093.
  • Wang GS, Levitan R, Wiegand TJ, et al. Extracorporeal membrane oxygenation (ECMO) for severe toxicological exposures: review of the toxicology investigators consortium (ToxIC). J Med Toxicol. 2016;12:95–99.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.